In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Vital Signs: Racial Disparities in Breast Cancer Severity — United

Stand Up 2 Breast Cancer

Reducing Racial Disparities in Cancer Care Using the ACCURE Trial

The impact of race and age on response to neoadjuvant therapy and

Concomitant analyses of intratumoral microbiota and genomic

Disparities in Clinical Research and Cancer Treatment

Triple negative breast cancer: Pitfalls and progress

Pathologic complete response and overall survival in breast cancer

PDF) Racial disparity in distant recurrence-free survival in

PDF) Pathologic Complete Response After Neoadjuvant Chemotherapy

A Predictor of Pathological Complete Response to Neoadjuvant

Racial disparities in major cardiovascular and

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

pCR Rates Following Neoadjuvant Therapy Similar Between Black and

Genetics of Breast and Gynecologic Cancers (PDQ®) - NCI